The clinical manifestations, genetic patterns, and prevalence of myopathies vary in Brody myopathy and RYR1 mutation-associated myopathies, whereas an exon group analysis of a malignant hyperthermic family reported that all members of the family had ATP2A1 deletion of Brody myopathy. This evidence concerns the gene ATP2A1 and myopathy.